DR 4485 hydrochlorideHigh affinity and selective 5-HT7 antagonist; orally bioavailable CAS# 402942-53-4 |
Related Products
- MK-4827
Catalog No.:BCC1761
CAS No.:1038915-60-4
- BMN-673 8R,9S
Catalog No.:BCC1422
CAS No.:1207456-00-5
- XAV-939
Catalog No.:BCC1120
CAS No.:284028-89-3
- PJ34
Catalog No.:BCC1865
CAS No.:344458-19-1
- ABT-888 (Veliparib)
Catalog No.:BCC1267
CAS No.:912444-00-9
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 402942-53-4 | SDF | Download SDF |
| PubChem ID | 90488996 | Appearance | Powder |
| Formula | C26H29Cl3N2O | M.Wt | 491.88 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble to 100 mM in DMSO | ||
| Chemical Name | 6-chloro-2a-[4-[4-(4-chlorophenyl)-3,6-dihydro-2H-pyridin-1-yl]butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one;hydrochloride | ||
| SMILES | C1CC2=C(C=CC3=C2C(C1)(C(=O)N3)CCCCN4CCC(=CC4)C5=CC=C(C=C5)Cl)Cl.Cl | ||
| Standard InChIKey | QAERYGXKDZHTFR-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C26H28Cl2N2O.ClH/c27-20-7-5-18(6-8-20)19-11-16-30(17-12-19)15-2-1-13-26-14-3-4-21-22(28)9-10-23(24(21)26)29-25(26)31;/h5-11H,1-4,12-17H2,(H,29,31);1H | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | High affinity and selective 5-HT7 antagonist (pKi = 8.14). Exhibits selectivity for 5-HT7 over other 5-HT receptors. Inhibits 5-HT-induced cAMP accumulation in HEK-293 cells expressing the 5-HT7 receptor. Orally bioavailable. |
DR 4485 hydrochloride Dilution Calculator
DR 4485 hydrochloride Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.033 mL | 10.1651 mL | 20.3302 mL | 40.6603 mL | 50.8254 mL |
| 5 mM | 0.4066 mL | 2.033 mL | 4.066 mL | 8.1321 mL | 10.1651 mL |
| 10 mM | 0.2033 mL | 1.0165 mL | 2.033 mL | 4.066 mL | 5.0825 mL |
| 50 mM | 0.0407 mL | 0.2033 mL | 0.4066 mL | 0.8132 mL | 1.0165 mL |
| 100 mM | 0.0203 mL | 0.1017 mL | 0.2033 mL | 0.4066 mL | 0.5083 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Featured Products
- 7-Methoxyneochamaejasmine A
Catalog No.:BCN3134
CAS No.:402828-38-0
- SB 399885 hydrochloride
Catalog No.:BCC7595
CAS No.:402713-81-9
- Deacetylcinobufagin
Catalog No.:BCN2720
CAS No.:4026-95-3
- Firategrast
Catalog No.:BCC1575
CAS No.:402567-16-2
- NSC 693868
Catalog No.:BCC7208
CAS No.:40254-90-8
- DMeOB
Catalog No.:BCC7213
CAS No.:40252-74-2
- Acetylcimigenol 3-O-alpha-L-arabinopyranside
Catalog No.:BCN1447
CAS No.:402513-88-6
- ONO-AE3-208
Catalog No.:BCC1822
CAS No.:402473-54-5
- Glycitin
Catalog No.:BCN5895
CAS No.:40246-10-4
- 5-O-Feruloylquinic acid
Catalog No.:BCN3788
CAS No.:40242-06-6
- H-Hyp-OMe.HCl
Catalog No.:BCC3248
CAS No.:40216-83-9
- H-Orn-OMe.2HCl
Catalog No.:BCC3001
CAS No.:40216-82-8
New Products
- Telaprevir (VX-950)
Catalog No.:BCC2107
CAS No.:402957-28-2
- MDL 12330A hydrochloride
Catalog No.:BCC7066
CAS No.:40297-09-4
- Cassyfiline
Catalog No.:BCN4763
CAS No.:4030-51-7
- p-Menth-1-ene-3,6-diol
Catalog No.:BCN5454
CAS No.:4031-55-4
- Isoneobavaisoflavone
Catalog No.:BCN3195
CAS No.:40357-43-5
- Obtusafuran methyl ether
Catalog No.:BCN8103
CAS No.:40357-59-3
- Cannabisin H
Catalog No.:BCN3896
CAS No.:403647-08-5
- Qc 1
Catalog No.:BCC6356
CAS No.:403718-45-6
- 10058-F4
Catalog No.:BCC1050
CAS No.:403811-55-2
- HEMADO
Catalog No.:BCC7118
CAS No.:403842-38-6
- Benzyl 2-hydroxy-6-(beta-glucosyloxy)benzoate
Catalog No.:BCN7434
CAS No.:403857-21-6
- 6-Methoxykaempferol 3-O-rutinoside
Catalog No.:BCN2379
CAS No.:403861-33-6
Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.[Pubmed:19326916]
J Med Chem. 2009 Apr 23;52(8):2384-92.
We report the synthesis of a new set of compounds of general structure I (1-20) with structural modifications in the pharmacophoric elements of the previously reported lead UCM-5600. The new derivatives have been evaluated for binding affinity at 5-HT(7) and 5-HT(1A) receptors. The influence of the different structural features in terms of 5-HT(7)/5-HT(1A) receptor affinity and selectivity was analyzed by computational simulations of the complexes between compounds I and beta(2)-based 3-D models of these receptors. Compound 18 (HYD(1) = 1,3-dihydro-2H-indol-2-one; spacer = -(CH(2))(4)-; HYD(2) + HYD(3) = 3,4-dihydroisoquinolin-2(1H)-yl) exhibits high 5-HT(7)R affinity (K(i) = 7 nM) and selectivity over the 5-HT(1A)R (31-fold), and has been characterized as a partial agonist of the human 5-HT(7)R.
New tetrahydrobenzindoles as potent and selective 5-HT(7) antagonists with increased In vitro metabolic stability.[Pubmed:12467617]
Bioorg Med Chem Lett. 2003 Jan 6;13(1):61-4.
Chemical modifications of compound 1 (DR4004), a potent, selective antagonist of the 5-HT(7) receptor, were conducted with the aim of improving its metabolic stability. Halogenation of putative sites of oxidative metabolism afforded compounds 7-10, which retained high affinity and selectivity for the 5-HT(7) receptor, and showed increased in vitro metabolic stability. Compound 10 (DR4485) showed oral bioavailability, and should be a useful tool for evaluating the therapeutic potential of 5-HT(7) antagonists.
DR 4485 hydrochloride,402942-53-4,Natural Products,5-HT Receptor, buy DR 4485 hydrochloride , DR 4485 hydrochloride supplier , purchase DR 4485 hydrochloride , DR 4485 hydrochloride cost , DR 4485 hydrochloride manufacturer , order DR 4485 hydrochloride , high purity DR 4485 hydrochloride
